Gilla Kaplan is of Tyra Biosciences, Inc.. Currently has a direct ownership of 37,809 shares of TYRA, which is worth approximately $382,627. The most recent transaction as insider was on Jun 16, 2025, when has been sold 6,814 shares (Common Stock) at a price of $10.38 per share, resulting in proceeds of $70,729. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.8K
57.81% 3M change
57.81% 12M change
Total Value Held $382,627

GILLA KAPLAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2025
SELL
Open market or private sale
$70,729 $10.38 p/Share
6,814 Reduced 15.27%
37,809 Common Stock
Jun 13 2025
SELL
Open market or private sale
$154,650 $10.31 p/Share
15,000 Reduced 25.16%
44,623 Common Stock
Jun 12 2025
SELL
Open market or private sale
$309,300 $10.31 p/Share
30,000 Reduced 33.47%
59,623 Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
$37,449 $0.61 p/Share
61,392 Added 40.65%
89,623 Common Stock

Also insider at

AVTX
Avalo Therapeutics, Inc. Healthcare
GK

Gilla Kaplan

Rockville, MD

Track Institutional and Insider Activities on TYRA

Follow Tyra Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TYRA shares.

Notify only if

Insider Trading

Get notified when an Tyra Biosciences, Inc. insider buys or sells TYRA shares.

Notify only if

News

Receive news related to Tyra Biosciences, Inc.

Track Activities on TYRA